Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Gross Profit (2016 - 2025)

Historic Gross Profit for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.1 million.

  • Jaguar Health's Gross Profit fell 109.29% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 4680.26%. This contributed to the annual value of $4.0 million for FY2024, which is 2108.45% up from last year.
  • Per Jaguar Health's latest filing, its Gross Profit stood at $1.1 million for Q3 2025, which was down 109.29% from $512000.0 recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Gross Profit registered a high of $1.5 million during Q4 2022, and its lowest value of -$1.8 million during Q2 2021.
  • For the 5-year period, Jaguar Health's Gross Profit averaged around $378105.3, with its median value being $777000.0 (2022).
  • In the last 5 years, Jaguar Health's Gross Profit plummeted by 23110.93% in 2021 and then soared by 93181.82% in 2024.
  • Over the past 5 years, Jaguar Health's Gross Profit (Quarter) stood at -$218000.0 in 2021, then skyrocketed by 793.58% to $1.5 million in 2022, then plummeted by 49.14% to $769000.0 in 2023, then increased by 3.25% to $794000.0 in 2024, then soared by 36.78% to $1.1 million in 2025.
  • Its Gross Profit was $1.1 million in Q3 2025, compared to $512000.0 in Q2 2025 and -$279000.0 in Q1 2025.